Obstructive Pulmonary Diseases

OLDs Overview - Defining the Battlefield

• Obstructive Lung Diseases (OLDs): Chronic expiratory airflow limitation from ↑ airway resistance. Reversible (Asthma) or irreversible (COPD).
• Key Diagnostic: Pulmonary Function Tests (PFTs).
  • Hallmark: ↓ $FEV_1/FVC$ ratio < 0.7.
  • ↓ $FEV_1$ significantly. FVC normal/mildly ↓.
  • ↑ TLC & RV (air trapping).
• Major OLDs:
  • Asthma
  • COPD (Chronic Bronchitis, Emphysema)
  • Bronchiectasis
  • Cystic Fibrosis

⭐ A key feature distinguishing COPD from asthma is the largely irreversible nature of airflow obstruction in COPD, confirmed by post-bronchodilator spirometry showing FEV1/FVC < 0.7.

COPD - The Smoker's Scourge

COPD: progressive, irreversible airflow limitation. Key types: Chronic Bronchitis & Emphysema.

⭐ Alpha-1 antitrypsin deficiency (AATD) is a key genetic risk factor for early-onset panacinar emphysema, especially in non-smokers.

Asthma - The Wheezing Wail

• Chronic airway inflammation: reversible bronchoconstriction, hyperresponsiveness (AHR).
• Triggers: Allergens (dust, pollen), URIs, exercise, cold air, NSAIDs, β-blockers.
• Pathophysiology:
  • Early (minutes): IgE mast cell degranulation → histamine, $LTC_4$/$LTD_4$/$LTE_4$, $PGD_2$ → bronchospasm, edema, mucus.
  • Late (hours): Eosinophils (MBP, ECP), Th2 cells → sustained inflammation, AHR, remodeling (smooth muscle hypertrophy, BM thickening).

• Microscopic:
  • Curschmann spirals (whorled mucus plugs).
  • Charcot-Leyden crystals (eosinophil-derived galectin-10 crystals).
  • Eosinophilic infiltrate, thickened basement membrane, goblet cell hyperplasia.
  • 
• Clinical: Episodic wheeze, cough (nocturnal), dyspnea, chest tightness. Status asthmaticus = severe attack.
• Types: Extrinsic (atopic, IgE, childhood); Intrinsic (non-atopic, adult, non-immune triggers).

⭐ Samter's Triad (AERD): Asthma, aspirin/NSAID sensitivity, and nasal polyps. Due to ↑leukotrienes from arachidonic acid pathway shunting.

Bronchiectasis - Dilated Airways Drama

• Permanent, irreversible dilation of bronchi/bronchioles; destruction of muscle/elastic tissue by chronic necrotizing infections.
• Etiology:
  • Post-infectious (TB, pneumonia, measles, pertussis).
  • Congenital (Cystic Fibrosis, Kartagener's syndrome, Young's syndrome).
  • Bronchial Obstruction (tumor, foreign body, mucoid impaction).
  • Allergic Bronchopulmonary Aspergillosis (ABPA).
  • Immunodeficiency states (e.g., hypogammaglobulinemia).
• Pathogenesis: "Vicious cycle": inflammation → airway damage → impaired mucociliary clearance → recurrent infection.
• Morphology:
  • Types: Cylindrical (most common), varicose, saccular/cystic (worst prognosis). Airways dilated up to 4x normal.
  • Dilated airways often extend to pleural surface; histology shows acute/chronic inflammation, fibrosis, ulceration.
• Clinical Features:
  • Persistent cough; copious, foul-smelling, purulent sputum (may form three layers upon standing).
  • Hemoptysis (can be massive), dyspnea, recurrent febrile episodes, clubbing of fingers.
• Diagnosis:
  • HRCT Chest (gold standard): Shows dilated airways.
    • "Signet ring" sign (dilated bronchus > adjacent pulmonary artery).
    • "Tram-track" appearance (thickened, non-tapering bronchial walls).

⭐ Kartagener's syndrome, a primary ciliary dyskinesia, classically presents with the triad: situs inversus, chronic sinusitis, and bronchiectasis.

• Complications: Recurrent pneumonia, lung abscess, empyema, massive hemoptysis, respiratory failure, cor pulmonale, secondary amyloidosis (AA).

High‑Yield Points - ⚡ Biggest Takeaways

• Hallmark: FEV1/FVC ratio < 0.7; ↑ TLC & RV from air trapping.
• Emphysema ("Pink Puffer"): Alveolar destruction, ↓ recoil; centriacinar (smoking), panacinar (α1-antitrypsin deficiency).
• Chronic Bronchitis ("Blue Bloater"): Productive cough (3 months/yr, 2 yrs), Reid Index > 0.5.
• Asthma: Reversible bronchoconstriction, type I hypersensitivity, eosinophils, Charcot-Leyden crystals, Curschmann spirals.
• Bronchiectasis: Irreversible bronchial dilation, foul purulent sputum, linked to cystic fibrosis, Kartagener's syndrome_